Scientific Paper

A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates

April 27, 2023

A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates

Back to Resources

At Atuka, we combine our capabilities with yours to harness the power of partnership and advance your therapeutic program.

Talk to a Neuroscience Expert